Subscribe to Biological Therapies in Psychiatry -  Choose your plan >
IN THIS MONTH'S ISSUE:
January 2017

Can Statins Augment SSRIs?
Combining statins with a selective serotonin reuptake inhibitor (SSRI) might lower the risk for and symptoms of depression.

Lithium Intoxication: A New Study
Lithium toxicity is uncommon, but clinicians should test lithium blood levels when indicated and discuss risks with patients during treatment planning.

Whole-Body Hyperthermia for MDD?
Preliminary data suggest whole-body hyperthermia should be tested further as a potential new treatment for depression.

In Brief
Large Study Shows Decline in Dementia Prevalence in the United States between 2000 and 2012; Transitions to Daylight Savings Time Is Associated with an Increase in Depression

Oral Health in Patients with Mood and Anxiety Disorders
Patients with psychiatric disorders should be regularly screened for oral health and referred for dental care as needed.

Testosterone Supplementation: More Negative Evidence
A literature review of 156 studies concluded that the benefits of testosterone supplementation do not outweigh the risks for any population of normal men.

A Message from Alan J. Gelenberg, M.D.

When I first started writing BTP in the 1970s, it was to bridge the gap between new knowledge in our field and its application to patient care. Over the decades since, the need for this bridge has become even greater. Neuroscience rockets forward. Psychiatrists and other clinicians have a broader array of treatments for patients with mental disorders than we even dreamed of back then. But we have less time to spend with patients and less time to keep up with developments that affect treatment decisions. Our medications, and those prescribed by colleagues in other specialties, are more varied, complex, and prone to interactions. What were formerly crisp boundaries between major psychopharmacologic categories are now murky.

This makes the modern practice of psychiatry challenging—but also fun and promising. With the expanding armamentarium of treatment options comes enhanced ability to alleviate suffering. The mission of BTP remains constant, even while the field grows. We are still here to bridge the gap, to make science applicable and relevant, and to help you in your day-to-day work relieve distress and improve function in patients' lives.